US Patent Issued to Tay Therapeutics on Aug. 12 for "Compounds comprising N-methyl-2-pyridone, and pharmaceutically acceptable salts" (British Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,777, issued on Aug. 12, was assigned to Tay Therapeutics Ltd. (Dundee, Great Britain).

"Compounds comprising N-methyl-2-pyridone, and pharmaceutically acceptable salts" was invented by Christopher Andrew Woodland (Dundee, Great Britain) and Mark Bell (Dundee, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention concerns compounds comprising N-methyl-2-pyridone, and pharmaceutically-acceptable salts and compositions of such compounds. Such compounds are useful in anti-inflammatory and anti-cancer therapies. Therefore, the present invention also concerns such compounds for use as medicaments, particularly for the treatmen...